Literature DB >> 11570639

Natural killer cell activity, serum immunoglobulins, complement proteins, and zinc levels in patients with psoriasis vulgaris.

G Oztürk1, D Erbaş, E Gelir, A Gülekon, T Imir.   

Abstract

The role of the immune system in patients with psoriasis vulgaris (PV) was investigated. The genetic and immunological basis for psoriasis is still unknown. Because of the reports of immunological defects in this disease, we investigated serum levels of immunoglobulins IgG, IgM, IgA, complement proteins C3, C4, serum zinc (Zn) levels and natural killer (NK) cell activities. Skin lesions of the psoriatic patients involved in the study comprised less than 10 % of the total body and the disease was in a stationary period. Zn levels were measured by atomic absorption spectrophotometry. NK cell activity was measured by 51Cr (Na2 51CrO4). IgG, IgA, IgM, C3 and C4 assays were done by liquid-phase immunoprecipitation assay with nephelometric endpoint detection. IgG, IgA, C3 and C4 levels were significanty higher in patients with PV than in healty controls (p < 0.05). However, NK cell activity, serum Zn and IgM levels did not show significant differences between these two groups. There are changed immunological responses, which may play an important role in the pathogenesis of the disease. Many controversial results have been related to immunological parameters in psoriatic patients. Therefore, more detailed studies in this field need to be done to determine the relationship between psoriasis and the immune system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11570639     DOI: 10.1081/imm-100105063

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  2 in total

1.  Serum Zinc Levels in Cutaneous Disorders.

Authors:  P N Arora; K S Dhillon; S R Rajan; S K Sayal; A L Das
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  A Novel Evaluation System of Psoriasis Curative Effect Based on Bayesian Maximum Entropy Weight Self-Learning and Extended Set Pair Analysis.

Authors:  Le Kuai; Xiao-Ya Fei; Jing-Si Jiang; Xin Li; Ying Zhang; Yi Ru; Ying Luo; Jian-Kun Song; Wei Li; Shuang-Yi Yin; Bin Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-17       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.